Published in Cancer on February 01, 1986
Comparison of manually constructed and stapled anastomoses in colorectal surgery. West of Scotland and Highland Anastomosis Study Group. Ann Surg (1995) 2.30
Bowel anastomoses: The theory, the practice and the evidence base. World J Gastrointest Surg (2012) 0.99
Problems associated with the EEA stapling technique for esophagojejunostomy after total gastrectomy. Ann Surg (1989) 0.87
A randomized study comparing outcomes of stapled and hand-sutured anastomoses in patients undergoing open gastrointestinal surgery. Indian J Surg (2012) 0.84
Safety and effectiveness of mechanical versus hand suturing of intestinal anastomoses in an animal model of peritonitis. Exp Ther Med (2012) 0.82
Comparison of standard 4-row versus 6-row3-D linear cutter stapler in creation of gastrointestinal system anastomoses: a prospective randomized trial. Clinics (Sao Paulo) (2012) 0.81
The effect of tissue compression on circular stapler line failure. Surg Endosc (2011) 0.80
Higher frequency of anastomotic leakage with stapled compared to hand-sewn ileocolic anastomosis in a large population-based study. World J Surg (2015) 0.77
Multicenter prospective evaluation of a new articulating 5-mm endoscopic linear stapler. Surg Endosc (2015) 0.76
An Assessment of the Clinical and Economic Impact of Establishing Ileocolic Anastomoses in Right-Colon Resection Surgeries Using Mechanical Staplers Compared to Hand-Sewn Technique. Surg Res Pract (2015) 0.75
Is "functional end-to-end anastomosis" really functional? A review of the literature on stapled anastomosis using linear staplers. Surg Today (2016) 0.75
Long-term complications associated with prosthetic repair of incisional hernias. Arch Surg (1998) 6.63
Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J Clin Microbiol (2000) 6.33
Evaluation of the Repliscan system for identification of Enterobacteriaceae. J Clin Microbiol (1978) 5.07
Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome (1997) 4.15
In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species. Antimicrob Agents Chemother (1996) 3.82
A type VII myosin encoded by the mouse deafness gene shaker-1. Nature (1995) 3.71
Helpers: effects of experimental removal on reproductive success. Science (1982) 3.70
A systematic, genome-wide, phenotype-driven mutagenesis programme for gene function studies in the mouse. Nat Genet (2000) 3.63
Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat (2011) 3.40
Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg (1978) 3.37
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol (2008) 2.95
Mutations in the myosin VIIA gene cause non-syndromic recessive deafness. Nat Genet (1997) 2.88
Fluconazole disk diffusion procedure for determining susceptibility of Candida species. J Clin Microbiol (1996) 2.70
Isolation and characterization of Suv39h2, a second histone H3 methyltransferase gene that displays testis-specific expression. Mol Cell Biol (2000) 2.56
Sequence interpretation. Functional annotation of mouse genome sequences. Science (2001) 2.54
Myosin VIIa participates in opsin transport through the photoreceptor cilium. J Neurosci (1999) 2.44
Autosomal dominant non-syndromic deafness caused by a mutation in the myosin VIIA gene. Nat Genet (1997) 2.40
Precision and accuracy of fluconazole susceptibility testing by broth microdilution, Etest, and disk diffusion methods. Antimicrob Agents Chemother (2002) 2.33
Shaker-1 mutations reveal roles for myosin VIIA in both development and function of cochlear hair cells. Development (1998) 2.23
In vitro activities of daptomycin against 2,789 clinical isolates from 11 North American medical centers. Antimicrob Agents Chemother (2001) 2.14
Organization and evolutionary progress of a dispersed repetitive family of sequences in widely separated rodent genomes. J Mol Biol (1981) 2.10
A radiation hybrid map of mouse genes. Nat Genet (2001) 2.03
Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods. J Clin Microbiol (2009) 1.99
Cloning of a novel member of the low-density lipoprotein receptor family. Gene (1998) 1.97
Cytotoxic activity of lymphocytes. V. Role of soluble toxin in macrophage-inhibited cultures of tumor cells. J Immunol (1975) 1.88
Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcium on in vitro tests. Diagn Microbiol Infect Dis (2000) 1.82
Pneumococcal adherence to human epithelial cells. Infect Immun (1979) 1.82
Susceptibility of multi-resistant Streptococcus pneumoniae to ciprofloxacin, ofloxacin and levofloxacin. J Antimicrob Chemother (1997) 1.79
Decreased skin-test reactivity associated with influenza. J Infect Dis (1972) 1.74
Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin). Antimicrob Agents Chemother (1998) 1.67
In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae. Antimicrob Agents Chemother (1998) 1.63
In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits. J Antimicrob Chemother (1996) 1.59
Serum factors responsible for killing of Shigella. Immunology (1974) 1.56
Microdissection of and microcloning from the short arm of human chromosome 2. Mol Cell Biol (1986) 1.55
Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med (1980) 1.54
Classical and alternative complement pathway activation by pneumococci. Infect Immun (1977) 1.54
Complement system in pneumococcal infections. Infect Immun (1976) 1.50
Routine chest roentgenography is unnecessary in the work-up of stage I and II breast cancer. J Clin Oncol (2000) 1.50
Prolonged venous access for chemotherapy by means of the Hickman catheter. Cancer (1983) 1.49
Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research. Head Neck (1992) 1.46
In vitro activities of ertapenem (MK-0826) against clinical bacterial isolates from 11 North American medical centers. Antimicrob Agents Chemother (2001) 1.45
Treatment of primary breast cancer with chemotherapy and tamoxifen. N Engl J Med (1981) 1.45
DNA topoisomerase I is essential in Drosophila melanogaster. Proc Natl Acad Sci U S A (1993) 1.44
Survival differences between black and white women with breast cancer. J Surg Oncol (1994) 1.44
In-vitro antimicrobial activity of a carbapenem, MK-0826 (L-749,345) and provisional interpretive criteria for disc tests. J Antimicrob Chemother (1999) 1.43
A mutation (2314delG) in the Usher syndrome type IIA gene: high prevalence and phenotypic variation. Am J Hum Genet (1999) 1.42
Natural history of adrenal cortical carcinoma: a clinicopathologic study of 42 patients. Cancer (1981) 1.40
Bacterial adherence: first step in pathogenesis of certain infections. J Chronic Dis (1978) 1.37
Mutations in the myosin VIIA gene cause a wide phenotypic spectrum, including atypical Usher syndrome. Am J Hum Genet (1998) 1.36
Myosin VIIA is required for aminoglycoside accumulation in cochlear hair cells. J Neurosci (1997) 1.36
Metastatic carcinomas from occult primary tumors. A study of 254 patients. Ann Surg (1977) 1.34
Analysis of the Pax-3 gene in the mouse mutant splotch. Genomics (1993) 1.34
High-performance liquid-chromatographic assay of aminoglycoside antibiotics in serum. Clin Chem (1978) 1.34
Intestinal immunoglobulins in shigellosis. Gastroenterology (1971) 1.33
Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism. Epilepsia (2000) 1.32
Adherent microorganisms on lumenal surfaces of long-term intravenous catheters. Importance of Staphylococcus epidermidis in patients with cancer. Arch Intern Med (1986) 1.29
Genetics of deafness. Curr Opin Neurobiol (1996) 1.28
The mouse slalom mutant demonstrates a role for Jagged1 in neuroepithelial patterning in the organ of Corti. Hum Mol Genet (2001) 1.28
The kyphoscoliosis (ky) mouse is deficient in hypertrophic responses and is caused by a mutation in a novel muscle-specific protein. Hum Mol Genet (2001) 1.27
The murine polycomb-group genes Ezh1 and Ezh2 map close to Hox gene clusters on mouse chromosomes 11 and 6. Mamm Genome (1999) 1.26
Adherence of group A streptococci to pharyngeal cells: a role in the pathogenesis of rheumatic fever. Science (1978) 1.25
Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA. J Antimicrob Chemother (1997) 1.25
Alternate-day prednisone therapy after renal transplantation. Lancet (1970) 1.25
Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res (1997) 1.24
Effects of shaker-1 mutations on myosin-VIIa protein and mRNA expression. Cell Motil Cytoskeleton (1997) 1.24
In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients. Antimicrob Agents Chemother (2006) 1.24
Construction of a mouse yeast artificial chromosome library in a recombination-deficient strain of yeast. Nat Genet (1992) 1.23
Beta-adrenergic blocking activity of Yersinia pestis murine toxin. Infect Immun (1977) 1.22
Perceptual organization of acoustic stimuli by budgerigars (Melopsittacus undulatus): I. Pure tones. J Comp Psychol (1987) 1.22
A YAC-based physical map of the mouse genome. Nat Genet (1999) 1.22
Isolation, physical mapping, and northern analysis of the X-linked human gene encoding methyl CpG-binding protein, MECP2. Mamm Genome (1996) 1.20
A prospective and blinded investigation of magnetic resonance imaging of the knee. Abnormal findings in asymptomatic subjects. Clin Orthop Relat Res (1992) 1.20
Expression of the type I diabetes-associated gene LRP5 in macrophages, vitamin A system cells, and the Islets of Langerhans suggests multiple potential roles in diabetes. J Histochem Cytochem (2000) 1.20
Characterization of VSG gene expression site promoters and promoter-associated DNA rearrangement events. Mol Cell Biol (1991) 1.19
Mutation analysis of the mouse myosin VIIA deafness gene. Genes Funct (1997) 1.19
Large numbers of mice established by in vitro fertilization with cryopreserved spermatozoa: implications and applications for genetic resource banks, mutagenesis screens, and mouse backcrosses. Mamm Genome (1999) 1.19
The gene mutated in bare patches and striated mice encodes a novel 3beta-hydroxysteroid dehydrogenase. Nat Genet (1999) 1.18
In vitro activities of clinafloxacin against contemporary clinical bacterial isolates from 10 North American centers. Antimicrob Agents Chemother (1998) 1.17
In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae. Eur J Clin Microbiol Infect Dis (1997) 1.17
Carcinoembryonic antigen (CEA) in feces and plasma of normal subjects and patients with colorectal carcinoma. Dis Colon Rectum (1974) 1.15
Mutations in connexin31 underlie recessive as well as dominant non-syndromic hearing loss. Hum Mol Genet (2000) 1.15
Permanent Genetic Resources added to Molecular Ecology Resources Database 1 May 2009-31 July 2009. Mol Ecol Resour (2009) 1.15
Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis. Infect Immun (1977) 1.15
A high-resolution microsatellite map of the mouse genome. Genome Res (1998) 1.14
Reactions between certain strains of pneumococci and Fc of IgG. J Immunol (1974) 1.14
In vitro activities of five fluoroquinolone compounds against strains of Streptococcus pneumoniae with resistance to other antimicrobial agents. Antimicrob Agents Chemother (1996) 1.14
Comparative genome sequence analysis of the Bpa/Str region in mouse and Man. Genome Res (2000) 1.13
The specific organisation of satellite DNA sequences on the X-chromosome of Mus musculus: partial independence of chromosome evolution. Nucleic Acids Res (1980) 1.13
Myosin VIIA gene: heterogeneity of the mutations responsible for Usher syndrome type IB. Hum Mol Genet (1997) 1.13
Model for studying bacterial adherence to epithelial cells infected with viruses. Infect Immun (1981) 1.12
Implementation of a large-scale ENU mutagenesis program: towards increasing the mouse mutant resource. Mamm Genome (2000) 1.11
Criteria for testing the susceptibility of Streptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 microgram or 30 micrograms cefotaxime disks. Eur J Clin Microbiol Infect Dis (1995) 1.11
Mastopathy in insulin-requiring diabetes mellitus. Hum Pathol (1994) 1.11
The sequence and gene characterization of a 400-kb candidate region for IDDM4 on chromosome 11q13. Genomics (2001) 1.11
Hepatic resection using intermittent vascular inflow occlusion and low central venous pressure anesthesia improves morbidity and mortality. J Gastrointest Surg (2000) 1.11
Renal toxicity in man treated with mitomycin C. Cancer (1971) 1.11
Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg Gynecol Obstet (1989) 1.10